Argentina

Argentina

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
2.1 (1.40 - 2.80) 1999 Survey/reported Silveira TR et al, 1999
0.06 (0.05 - 0.09) 2015 Modelled WHO
0.2 (0.10 - 0.30) 2016 Modelled Razavi-Shearer et al, 2018
0.77 (0.77 - 0.78) 2013 Modelled Schweitzer et al, 2015
0.4 (0.30 - 0.50) 2019 Survey/reported WHO
0.35 (0.30 - 0.40) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.39 (0.34 - 0.45) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.39 (0.34 - 0.46) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.39 (0.34 - 0.45) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.39 (0.34 - 0.45) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.4 (0.34 - 0.45) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.4 (0.34 - 0.46) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.41 (0.35 - 0.46) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.42 (0.35 - 0.48) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.42 (0.35 - 0.48) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.42 (0.36 - 0.49) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.43 (0.36 - 0.49) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.43 (0.36 - 0.50) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.44 (0.37 - 0.51) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.44 (0.37 - 0.51) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.44 (0.37 - 0.51) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.44 (0.37 - 0.52) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.44 (0.37 - 0.52) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.44 (0.38 - 0.52) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.45 (0.37 - 0.52) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.45 (0.38 - 0.52) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.45 (0.38 - 0.53) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.46 (0.38 - 0.53) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.46 (0.38 - 0.53) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.46 (0.38 - 0.54) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.46 (0.38 - 0.54) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.46 (0.38 - 0.54) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.46 (0.38 - 0.54) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.46 (0.38 - 0.54) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.46 (0.38 - 0.54) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.39 (0.34 - 0.44) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.01 (0.01 - 0.01) 2015 Modelled WHO
0.02 (0.01 - 0.03) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.03 (0.02 - 0.04) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.04) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.04) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.04) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.04) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.04) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.04) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.04) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.04) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.04) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.04) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.03 (0.02 - 0.05) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.02 - 0.05) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.06) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.05 (0.03 - 0.07) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.05 (0.03 - 0.07) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.04 - 0.08) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.07 (0.05 - 0.09) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.08 (0.05 - 0.11) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.09 (0.06 - 0.12) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.11 (0.07 - 0.15) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.14 (0.09 - 0.19) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.17 (0.11 - 0.23) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.19 (0.12 - 0.27) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.2 (0.12 - 0.28) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.2 (0.12 - 0.28) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.2 (0.13 - 0.28) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.2 (0.13 - 0.28) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.2 (0.13 - 0.28) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.19 (0.12 - 0.28) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.01 (0.01 - 0.02) 2020 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
79,000 (47,000 - 117,000) 2016 Modelled Razavi-Shearer et al, 2018
157,094 (134,855 - 179,476) 2019 Modelled IHME, GBD 2019 (accessed 2020)
164,785 (142,336 - 188,151) 2019 Modelled IHME, GBD 2019 (accessed 2022)
163,604 (141,616 - 186,974) 2018 Modelled IHME, GBD 2019 (accessed 2022)
162,454 (140,053 - 189,658) 2017 Modelled IHME, GBD 2019 (accessed 2022)
161,287 (139,012 - 184,136) 2016 Modelled IHME, GBD 2019 (accessed 2022)
160,288 (136,965 - 183,885) 2015 Modelled IHME, GBD 2019 (accessed 2022)
160,083 (136,575 - 182,437) 2014 Modelled IHME, GBD 2019 (accessed 2022)
160,694 (136,804 - 182,800) 2013 Modelled IHME, GBD 2019 (accessed 2022)
161,573 (136,904 - 183,708) 2012 Modelled IHME, GBD 2019 (accessed 2022)
162,166 (137,221 - 185,701) 2011 Modelled IHME, GBD 2019 (accessed 2022)
161,891 (136,714 - 187,533) 2010 Modelled IHME, GBD 2019 (accessed 2022)
161,258 (136,387 - 186,036) 2009 Modelled IHME, GBD 2019 (accessed 2022)
160,983 (135,586 - 185,477) 2008 Modelled IHME, GBD 2019 (accessed 2022)
160,802 (135,105 - 186,141) 2007 Modelled IHME, GBD 2019 (accessed 2022)
160,353 (134,999 - 185,919) 2006 Modelled IHME, GBD 2019 (accessed 2022)
159,240 (134,680 - 184,938) 2005 Modelled IHME, GBD 2019 (accessed 2022)
157,794 (133,520 - 183,415) 2004 Modelled IHME, GBD 2019 (accessed 2022)
156,568 (132,842 - 182,546) 2003 Modelled IHME, GBD 2019 (accessed 2022)
155,510 (131,608 - 181,142) 2002 Modelled IHME, GBD 2019 (accessed 2022)
154,502 (130,353 - 179,594) 2001 Modelled IHME, GBD 2019 (accessed 2022)
153,428 (128,963 - 178,887) 2000 Modelled IHME, GBD 2019 (accessed 2022)
152,764 (128,204 - 177,884) 1999 Modelled IHME, GBD 2019 (accessed 2022)
152,743 (128,262 - 176,439) 1998 Modelled IHME, GBD 2019 (accessed 2022)
152,897 (127,754 - 177,104) 1997 Modelled IHME, GBD 2019 (accessed 2022)
152,762 (126,784 - 177,397) 1996 Modelled IHME, GBD 2019 (accessed 2022)
151,874 (124,958 - 178,209) 1995 Modelled IHME, GBD 2019 (accessed 2022)
150,458 (124,496 - 175,298) 1994 Modelled IHME, GBD 2019 (accessed 2022)
149,001 (123,510 - 174,042) 1993 Modelled IHME, GBD 2019 (accessed 2022)
147,440 (122,383 - 172,848) 1992 Modelled IHME, GBD 2019 (accessed 2022)
145,690 (120,147 - 170,717) 1991 Modelled IHME, GBD 2019 (accessed 2022)
143,695 (117,456 - 169,743) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more

Number of new cases of HBV

National
Download
Value Year Type Source
480 2019 Survey/reported Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis Argentina

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
0.07 2018 Survey/reported Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis Argentina
2.24 (1.67 - 2.99) 2019 Modelled IHME, GBD 2019 (accessed 2020)
3.08 (2.25 - 4.03) 1990 Modelled IHME, GBD 2019 (accessed 2022)
3.05 (2.23 - 3.98) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3.07 (2.25 - 3.99) 1992 Modelled IHME, GBD 2019 (accessed 2022)
3.01 (2.22 - 3.89) 1993 Modelled IHME, GBD 2019 (accessed 2022)
2.95 (2.18 - 3.80) 1994 Modelled IHME, GBD 2019 (accessed 2022)
2.95 (2.18 - 3.80) 1995 Modelled IHME, GBD 2019 (accessed 2022)
2.99 (2.19 - 3.86) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2.98 (2.19 - 3.87) 1996 Modelled IHME, GBD 2019 (accessed 2022)
2.98 (2.19 - 3.86) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2.97 (2.19 - 3.83) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2.89 (2.14 - 3.73) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2.91 (2.16 - 3.77) 2001 Modelled IHME, GBD 2019 (accessed 2022)
2.96 (2.20 - 3.83) 2002 Modelled IHME, GBD 2019 (accessed 2022)
3 (2.24 - 3.90) 2003 Modelled IHME, GBD 2019 (accessed 2022)
2.95 (2.19 - 3.85) 2004 Modelled IHME, GBD 2019 (accessed 2022)
2.98 (2.22 - 3.85) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2.97 (2.22 - 3.87) 2005 Modelled IHME, GBD 2019 (accessed 2022)
2.94 (2.20 - 3.84) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2.72 (2.05 - 3.57) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2.54 (1.90 - 3.32) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2.43 (1.82 - 3.19) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2.4 (1.80 - 3.15) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2.37 (1.76 - 3.13) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2.34 (1.75 - 3.07) 2013 Modelled IHME, GBD 2019 (accessed 2022)
2.29 (1.71 - 3) 2014 Modelled IHME, GBD 2019 (accessed 2022)
2.3 (1.71 - 3.01) 2015 Modelled IHME, GBD 2019 (accessed 2022)
2.35 (1.76 - 3.10) 2016 Modelled IHME, GBD 2019 (accessed 2022)
2.32 (1.73 - 3.08) 2017 Modelled IHME, GBD 2019 (accessed 2022)
2.24 (1.67 - 2.99) 2019 Modelled IHME, GBD 2019 (accessed 2022)
2.26 (1.69 - 3.01) 2018 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
1,517 2016 Modelled WHO
838 2018 Survey/reported Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis Argentina
1,019 (744 - 1,334) 1990 Modelled IHME, GBD 2019 (accessed 2022)
1,022 (747 - 1,334) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1,042 (763 - 1,352) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1,031 (760 - 1,333) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1,021 (755 - 1,315) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1,032 (764 - 1,330) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1,052 (775 - 1,368) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1,065 (781 - 1,377) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1,076 (790 - 1,392) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1,081 (798 - 1,393) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1,063 (787 - 1,373) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1,081 (803 - 1,403) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1,135 (842 - 1,478) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1,114 (829 - 1,441) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1,140 (849 - 1,484) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1,169 (873 - 1,513) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1,156 (861 - 1,504) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1,169 (874 - 1,525) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1,093 (822 - 1,433) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1,033 (772 - 1,349) 2009 Modelled IHME, GBD 2019 (accessed 2022)
998 (747 - 1,312) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1,001 (748 - 1,313) 2010 Modelled IHME, GBD 2019 (accessed 2022)
997 (741 - 1,318) 2012 Modelled IHME, GBD 2019 (accessed 2022)
995 (742 - 1,304) 2013 Modelled IHME, GBD 2019 (accessed 2022)
985 (734 - 1,291) 2014 Modelled IHME, GBD 2019 (accessed 2022)
999 (744 - 1,308) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1,032 (773 - 1,362) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1,013 (756 - 1,345) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1,027 (767 - 1,368) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1,012 (755 - 1,348) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1,012 (755 - 1,348) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
3 (2 - 5) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 5) 1992 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 5) 1990 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 5) 1993 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 5) 1994 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 5) 1995 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 5) 1998 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 5) 1996 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 5) 1997 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 5) 1999 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2000 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2002 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2001 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 2003 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 2004 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 2005 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2007 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 6) 2006 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2008 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2009 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 7) 2011 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2010 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 7) 2012 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 7) 2013 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 8) 2014 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 8) 2015 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 8) 2016 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 8) 2018 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 8) 2017 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 8) 2019 Modelled IHME, GBD 2019 (accessed 2022)
16 (11 - 23) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
82 2019 Survey/reported WHO/UNICEF
82 2018 Survey/reported WHO/UNICEF
80 2017 Survey/reported WHO/UNICEF
81 2016 Survey/reported WHO/UNICEF
84 2015 Survey/reported WHO/UNICEF
87 2014 Survey/reported WHO/UNICEF
85 2013 Survey/reported WHO/UNICEF
88 2012 Survey/reported WHO/UNICEF
85 2011 Survey/reported WHO/UNICEF
79 2010 Survey/reported WHO/UNICEF
81 2009 Survey/reported WHO/UNICEF
79 2008 Survey/reported WHO/UNICEF
76 2007 Survey/reported WHO/UNICEF
72 2006 Survey/reported WHO/UNICEF
71 2005 Survey/reported WHO/UNICEF
65 2004 Survey/reported WHO/UNICEF
72 2020 Survey/reported WHO/UNICEF
73 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
86 2019 Survey/reported WHO/UNICEF
74 2020 Survey/reported WHO/UNICEF
76 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Proportion of persons living with HBV diagnosed

National
Download
Value (%) Year Type Source
60 2019 Survey/reported Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis Argentina

Proportion of diagnosed HBV persons receiving appropriate treatment

National
Download
Value (%) Year Type Source
80 2019 Survey/reported Communications with Argentina Ministry of Health

Number of needles/syringes per PWID per year

National
Download
Value Year Type Source
20 2015 Survey/reported Respuesta a las hepatitis virales: Plan Estratégico Nacional 2018-2021
Technical notes
HBV National Action Plan
Source:
HBV elimination goal
Source:
Year of HBV elimination goal
2030
Source:
National prevalence survey within the last 5 years
Partially Adopted
Source: Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis Ar…
Estimates of economic burden
Partially Adopted
Source: Ropero Álvarez A.M. et al
System for monitoring testing and treatment
Adopted
Source: Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis Ar…
HepB birth dose policy
Yes
Source:
Year of birth dose introduction
2000
Source: WHO
Eligible for HBV generic medicines
Source: MPP
Licensed point-of-care PCR testing to detect HBV
Not Adopted
Source: Communciations with Ministry of Health
HBV testing policy
Universal
Source: Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis Ar…
No patient co-pays for HBsAg testing
Partially Adopted
Source: Communications with Argentina Ministry of Health
National treatment guidelines exist
Adopted
Source: Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis, M…
Simplified care: No treatment co-pays
Adopted
Communications with Argentina Ministry of Health
Public budget line for testing and treatment
Adopted
Source: PAHO
HCV National Action Plan
Source:
HCV elimination goal
Source:
Year of HCV elimination goal
2030
Source:
National prevalence survey within the last 5 years
Partially Adopted
Source: Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis Ar…
Estimates of economic burden
Partially Adopted
Source: Ropero Álvarez A.M. et al
System for monitoring testing and treatment
Adopted
Source: Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis Ar…
Registration of originator HCV DAAs
Adopted
Source: MapCrowd
Licensed point-of-care PCR testing to detect HCV
Not Adopted
Source: Communication with Ministry of Health
HCV testing policy
Universal
Source: Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis Ar…
No patient co-pays for anti-HCV testing
Partially Adopted
Source: Communications with Argentina Ministry of Health
National treatment guidelines exist
Adopted
Source: Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis, M…
Simplified care: Non-specialists can prescribe treatment
Adopted
Source: Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis, M…
Simplified care: No treatment co-pays
Adopted
Communications with Argentina Ministry of Health
No fibrosis restrictions
Adopted
Source: Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis, M…
No sobriety restrictions
Adopted
Source: Source: Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tubercu…
At least one needle-syringe exchange program (NSP) operational
No
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)
Source: WHO
Public budget line for testing and treatment
Adopted
Source: PAHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.8 (0.30 - 1.20) 2015 Modelled Blach et al, 2017
0.57 (0.49 - 0.68) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.57 (0.48 - 0.67) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.57 (0.48 - 0.67) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.56 (0.47 - 0.66) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.55 (0.46 - 0.66) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.54 (0.45 - 0.63) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.52 (0.43 - 0.61) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.49 (0.41 - 0.58) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.47 (0.39 - 0.56) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.45 (0.38 - 0.54) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.44 (0.37 - 0.53) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.43 (0.36 - 0.52) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.42 (0.36 - 0.50) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.42 (0.35 - 0.49) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.41 (0.35 - 0.49) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.41 (0.34 - 0.48) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.4 (0.34 - 0.48) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.4 (0.34 - 0.47) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.4 (0.33 - 0.47) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.39 (0.33 - 0.47) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.39 (0.33 - 0.46) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.39 (0.33 - 0.46) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.39 (0.33 - 0.46) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.39 (0.33 - 0.46) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.39 (0.33 - 0.46) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.4 (0.34 - 0.47) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.41 (0.35 - 0.48) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.43 (0.36 - 0.50) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.45 (0.38 - 0.53) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.48 (0.40 - 0.57) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.5 (0.40 - 0.60) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.52 (0.23 - 0.78) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
1.5 (0.50 - 2.50) 2014 Survey/reported Gower et al, 2014
1.5 2019 Modelled Jin et al. 2017
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
54.6 (51.10 - 58.10) 2001 Survey/reported Weissenbacher M et al, 2003
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
3.4 2019 Modelled Jin et al. 2017
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
326,000 (144,000 - 490,000) 2015 Modelled Blach et al, 2017
149,044 (124,316 - 177,094) 1990 Modelled IHME, GBD 2019 (accessed 2022)
142,862 (120,793 - 168,468) 1991 Modelled IHME, GBD 2019 (accessed 2022)
137,175 (115,767 - 160,669) 1992 Modelled IHME, GBD 2019 (accessed 2022)
132,560 (111,989 - 156,623) 1993 Modelled IHME, GBD 2019 (accessed 2022)
129,664 (109,238 - 153,221) 1994 Modelled IHME, GBD 2019 (accessed 2022)
129,097 (108,356 - 152,930) 1995 Modelled IHME, GBD 2019 (accessed 2022)
129,926 (109,459 - 154,087) 1996 Modelled IHME, GBD 2019 (accessed 2022)
130,881 (109,956 - 154,426) 1997 Modelled IHME, GBD 2019 (accessed 2022)
132,042 (110,701 - 155,965) 1998 Modelled IHME, GBD 2019 (accessed 2022)
133,502 (111,358 - 157,847) 1999 Modelled IHME, GBD 2019 (accessed 2022)
135,395 (113,169 - 160,169) 2000 Modelled IHME, GBD 2019 (accessed 2022)
137,691 (115,159 - 162,942) 2001 Modelled IHME, GBD 2019 (accessed 2022)
140,257 (117,824 - 166,122) 2002 Modelled IHME, GBD 2019 (accessed 2022)
143,086 (120,573 - 169,247) 2003 Modelled IHME, GBD 2019 (accessed 2022)
146,222 (123,539 - 172,829) 2004 Modelled IHME, GBD 2019 (accessed 2022)
149,664 (126,415 - 177,452) 2005 Modelled IHME, GBD 2019 (accessed 2022)
153,570 (129,389 - 182,108) 2006 Modelled IHME, GBD 2019 (accessed 2022)
158,060 (132,914 - 188,217) 2007 Modelled IHME, GBD 2019 (accessed 2022)
163,114 (136,935 - 194,589) 2008 Modelled IHME, GBD 2019 (accessed 2022)
168,675 (140,827 - 201,892) 2009 Modelled IHME, GBD 2019 (accessed 2022)
174,487 (144,933 - 208,733) 2010 Modelled IHME, GBD 2019 (accessed 2022)
182,446 (152,962 - 217,386) 2011 Modelled IHME, GBD 2019 (accessed 2022)
193,423 (162,789 - 230,775) 2012 Modelled IHME, GBD 2019 (accessed 2022)
205,563 (172,603 - 243,856) 2013 Modelled IHME, GBD 2019 (accessed 2022)
216,858 (182,947 - 257,130) 2014 Modelled IHME, GBD 2019 (accessed 2022)
225,110 (189,052 - 267,689) 2015 Modelled IHME, GBD 2019 (accessed 2022)
231,392 (195,201 - 273,534) 2016 Modelled IHME, GBD 2019 (accessed 2022)
236,735 (198,072 - 279,206) 2017 Modelled IHME, GBD 2019 (accessed 2022)
240,479 (202,927 - 283,624) 2018 Modelled IHME, GBD 2019 (accessed 2022)
223,803 (182,239 - 268,735) 2019 Modelled IHME, GBD 2019 (accessed 2020)
243,417 (205,867 - 288,519) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
58,200 (25,600 - 87,400) 2019 Modelled Dugan et al., 2021

Number of new cases of HCV

National
Download
Value Year Type Source
538 2019 Survey/reported Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis Argentina

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
0.22 2019 Survey/reported Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis Argentina
7.82 (6.26 - 9.59) 2019 Modelled IHME, GBD 2019 (accessed 2020)
6.5 (5.04 - 8.16) 1990 Modelled IHME, GBD 2019 (accessed 2022)
6.36 (4.94 - 7.94) 1991 Modelled IHME, GBD 2019 (accessed 2022)
6.35 (4.97 - 7.94) 1992 Modelled IHME, GBD 2019 (accessed 2022)
6.18 (4.85 - 7.76) 1993 Modelled IHME, GBD 2019 (accessed 2022)
6.03 (4.70 - 7.55) 1994 Modelled IHME, GBD 2019 (accessed 2022)
6.03 (4.72 - 7.55) 1995 Modelled IHME, GBD 2019 (accessed 2022)
6.1 (4.77 - 7.62) 1996 Modelled IHME, GBD 2019 (accessed 2022)
6.15 (4.82 - 7.70) 1997 Modelled IHME, GBD 2019 (accessed 2022)
6.18 (4.88 - 7.70) 1998 Modelled IHME, GBD 2019 (accessed 2022)
6.16 (4.89 - 7.67) 1999 Modelled IHME, GBD 2019 (accessed 2022)
6.01 (4.79 - 7.50) 2000 Modelled IHME, GBD 2019 (accessed 2022)
6.05 (4.83 - 7.50) 2001 Modelled IHME, GBD 2019 (accessed 2022)
6.13 (4.90 - 7.63) 2002 Modelled IHME, GBD 2019 (accessed 2022)
6.04 (4.81 - 7.46) 2004 Modelled IHME, GBD 2019 (accessed 2022)
6.17 (4.92 - 7.63) 2003 Modelled IHME, GBD 2019 (accessed 2022)
6.21 (4.94 - 7.67) 2006 Modelled IHME, GBD 2019 (accessed 2022)
6.06 (4.80 - 7.51) 2005 Modelled IHME, GBD 2019 (accessed 2022)
6.54 (5.18 - 8.07) 2007 Modelled IHME, GBD 2019 (accessed 2022)
6.56 (5.19 - 8.13) 2008 Modelled IHME, GBD 2019 (accessed 2022)
6.68 (5.28 - 8.25) 2009 Modelled IHME, GBD 2019 (accessed 2022)
6.83 (5.36 - 8.47) 2010 Modelled IHME, GBD 2019 (accessed 2022)
6.99 (5.53 - 8.68) 2011 Modelled IHME, GBD 2019 (accessed 2022)
7.14 (5.70 - 8.81) 2012 Modelled IHME, GBD 2019 (accessed 2022)
7.26 (5.82 - 8.92) 2013 Modelled IHME, GBD 2019 (accessed 2022)
7.31 (5.81 - 8.96) 2014 Modelled IHME, GBD 2019 (accessed 2022)
7.51 (6.01 - 9.26) 2015 Modelled IHME, GBD 2019 (accessed 2022)
7.86 (6.25 - 9.68) 2016 Modelled IHME, GBD 2019 (accessed 2022)
7.87 (6.27 - 9.72) 2017 Modelled IHME, GBD 2019 (accessed 2022)
7.79 (6.22 - 9.55) 2018 Modelled IHME, GBD 2019 (accessed 2022)
7.82 (6.26 - 9.59) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
1,599 2016 Modelled WHO
3,730 2019 Survey/reported Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis Argentina
3,527 (2,823 - 4,327) 2019 Modelled IHME, GBD 2019 (accessed 2022)
3,527 (2,823 - 4,327) 2019 Modelled IHME, GBD 2019 (accessed 2020)
3,484 (2,783 - 4,275) 2018 Modelled IHME, GBD 2019 (accessed 2022)
3,489 (2,780 - 4,313) 2017 Modelled IHME, GBD 2019 (accessed 2022)
3,451 (2,745 - 4,253) 2016 Modelled IHME, GBD 2019 (accessed 2022)
3,266 (2,612 - 4,024) 2015 Modelled IHME, GBD 2019 (accessed 2022)
3,142 (2,500 - 3,851) 2014 Modelled IHME, GBD 2019 (accessed 2022)
3,089 (2,473 - 3,792) 2013 Modelled IHME, GBD 2019 (accessed 2022)
3,005 (2,399 - 3,704) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2,907 (2,300 - 3,609) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2,808 (2,204 - 3,483) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2,716 (2,147 - 3,355) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2,637 (2,084 - 3,266) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2,597 (2,059 - 3,205) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2,440 (1,940 - 3,016) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2,356 (1,866 - 2,918) 2005 Modelled IHME, GBD 2019 (accessed 2022)
2,321 (1,847 - 2,868) 2004 Modelled IHME, GBD 2019 (accessed 2022)
2,343 (1,868 - 2,898) 2003 Modelled IHME, GBD 2019 (accessed 2022)
2,305 (1,840 - 2,869) 2002 Modelled IHME, GBD 2019 (accessed 2022)
2,248 (1,796 - 2,790) 2001 Modelled IHME, GBD 2019 (accessed 2022)
2,213 (1,761 - 2,760) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2,245 (1,783 - 2,794) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2,228 (1,758 - 2,775) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2,195 (1,721 - 2,747) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2,154 (1,687 - 2,694) 1996 Modelled IHME, GBD 2019 (accessed 2022)
2,108 (1,652 - 2,641) 1995 Modelled IHME, GBD 2019 (accessed 2022)
2,088 (1,628 - 2,614) 1994 Modelled IHME, GBD 2019 (accessed 2022)
2,120 (1,663 - 2,661) 1993 Modelled IHME, GBD 2019 (accessed 2022)
2,155 (1,685 - 2,694) 1992 Modelled IHME, GBD 2019 (accessed 2022)
2,133 (1,655 - 2,661) 1991 Modelled IHME, GBD 2019 (accessed 2022)
2,152 (1,670 - 2,701) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
6 (5 - 8) 1991 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 8) 1992 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 9) 1990 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 8) 1994 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 8) 1993 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 8) 1995 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 8) 1996 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 8) 1998 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 8) 1997 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 9) 1999 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 9) 2000 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 10) 2001 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 10) 2002 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 11) 2004 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 10) 2003 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 11) 2005 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 12) 2006 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 12) 2007 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 13) 2008 Modelled IHME, GBD 2019 (accessed 2022)
10 (8 - 13) 2009 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 14) 2010 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 14) 2011 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 15) 2013 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 14) 2012 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 15) 2014 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 15) 2015 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 15) 2016 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 15) 2017 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 15) 2018 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 15) 2019 Modelled IHME, GBD 2019 (accessed 2022)
36 (27 - 46) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Number of tests for HCV administered

National
Download
Value Year Year Type Source
276,480 2019 Survey/reported Communications with Argentina Ministry of Health
207,450 2018 Survey/reported Communications with Argentina Ministry of Health
Showing out of
Show more

Number of persons treated for HCV

National
Download
Value Year Type Source
1,200 2016 Survey/reported WHO, 2018
1,971 2019 Survey/reported Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis Argentina.
2,241 2018 Survey/reported Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis Argentina
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

National
Download
Value Year Type Source
20 2015 Survey/reported Respuesta a las hepatitis virales: Plan Estratégico Nacional 2018-2021
Technical notes

Proportion of persons living with HCV diagnosed

National
Download
Value (%) Year Type Source
50 2019 Survey/reported Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis Argentina

Proportion of persons diagnosed who were cured with new DAAs

National
Download
Value (%) Year Type Source
4.5 2019 Survey/reported Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis Argentina
HBV National Action Plan
Source:
HBV elimination goal
Source:
Year of HBV elimination goal
2030
Source:
National prevalence survey within the last 5 years
Partially Adopted
Source: Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis Ar…
Estimates of economic burden
Partially Adopted
Source: Ropero Álvarez A.M. et al
System for monitoring testing and treatment
Adopted
Source: Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis Ar…
HepB birth dose policy
Yes
Source:
Year of birth dose introduction
2000
Source: WHO
Eligible for HBV generic medicines
Source: MPP
Licensed point-of-care PCR testing to detect HBV
Not Adopted
Source: Communciations with Ministry of Health
HBV testing policy
Universal
Source: Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis Ar…
No patient co-pays for HBsAg testing
Partially Adopted
Source: Communications with Argentina Ministry of Health
National treatment guidelines exist
Adopted
Source: Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis, M…
Simplified care: No treatment co-pays
Adopted
Communications with Argentina Ministry of Health
Public budget line for testing and treatment
Adopted
Source: PAHO
HCV National Action Plan
Source:
HCV elimination goal
Source:
Year of HCV elimination goal
2030
Source:
National prevalence survey within the last 5 years
Partially Adopted
Source: Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis Ar…
Estimates of economic burden
Partially Adopted
Source: Ropero Álvarez A.M. et al
System for monitoring testing and treatment
Adopted
Source: Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis Ar…
Registration of originator HCV DAAs
Adopted
Source: MapCrowd
Licensed point-of-care PCR testing to detect HCV
Not Adopted
Source: Communication with Ministry of Health
HCV testing policy
Universal
Source: Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis Ar…
No patient co-pays for anti-HCV testing
Partially Adopted
Source: Communications with Argentina Ministry of Health
National treatment guidelines exist
Adopted
Source: Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis, M…
Simplified care: Non-specialists can prescribe treatment
Adopted
Source: Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis, M…
Simplified care: No treatment co-pays
Adopted
Communications with Argentina Ministry of Health
No fibrosis restrictions
Adopted
Source: Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis, M…
No sobriety restrictions
Adopted
Source: Source: Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tubercu…
At least one needle-syringe exchange program (NSP) operational
No
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)
Source: WHO
Public budget line for testing and treatment
Adopted
Source: PAHO

Overview

HBV elimination goal
Year of goal
2030
HCV elimination goal
Year of goal
2030

Prevalence (national)

Modelled

HBV (HBsAg+)
0.35 (%)
2019
(0.3 - 0.4(%))
IHME, GBD 2019 (accessed 2020)
HCV (RNA/cAg+)
0.57 (%)
2019
(0.49 - 0.68(%))
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

HBV (HBsAg+)
0.4 (%)
2019
(0.3 - 0.5(%))
WHO
HCV (anti-HCV)
1.5 (%)
2014
(0.5 - 2.5(%))
Gower et al, 2014

Hepatitis related deaths (national)

Modelled

HBV
1,012
2019
(755 - 1,348)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

HBV
838
2018
Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis Argentina
HBV chart

Modelled

HCV
3,527
2019
(2,823 - 4,327)
IHME, GBD 2019 (accessed 2020)

Survey/surveillance

HCV
3,730
2019
Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis Argentina
HCV chart

Prevalence < 5

HBV
0.01 (%)
2020, latest modelled
(0.01 - 0.02(%))
WHO

Prevalence PWID

HCV
54.60 (%)
2001, survey/surveillance
(51.10 - 58.10(%))
Weissenbacher M et al, 2003

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
73 (%)
2021
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Download National Hepatitis Elimination Profile (N-HEP)

Latest news

View all

Action plan

View all

News

Action plans

Resources

Partners